ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 661746 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 661746; 2) Community: the network communities that were significantly associated with the response to NSC 661746; 3) Molecule: the relationships between components within communities and NSC 661746; 4) MDR: the compounds that were significantly associated with the NSC 661746.

NSC Compound Enrichment Correlation
NSC 697912 5-Fluoro deoxy uridine 10mer 0.0392716453377535 -0.023637106
NSC 711077 Null 0.0392716453377535 0.30451943
NSC 715407 Null 0.0392716453377535 -0.049050785
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.36677544
NSC 720495 Null 0.0392716453377535 0.0083983075
NSC 725098 Null 0.0392716453377535 0.32989782
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0392716453377535 0.29056308
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0392716453377535 0.080504561
NSC 741459 (11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 0.0392716453377535 0.21893699
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0392716453377535 0.25675988
Total:82  Current:69    [First] [Prev] [Next] [Last]